Tokushima, Japan

Yoshitaka Hosokawa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Forsyth Dental Infirmary for Children. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshitaka Hosokawa. Retrieved from https://idiyas.com/inventor/yoshitaka-hosokawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshitaka Hosokawa

Introduction

Yoshitaka Hosokawa is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of oral health through his innovative research and development of antibacterial compositions.

Latest Patents

Hosokawa holds a patent for antibacterial compositions that are particularly useful in treating gum diseases such as gingivitis and periodontitis. His invention involves the use of trihydroxybenzoate derivatives, which have shown promise in improving oral health.

Career Highlights

He is currently associated with the Forsyth Dental Infirmary for Children, where he continues to advance research in dental health. His work has been instrumental in developing effective treatments for common oral health issues.

Collaborations

Some of his notable coworkers include Toshihisa Kawai and Philip P Stashenko, who have collaborated with him on various research projects.

Conclusion

Yoshitaka Hosokawa's contributions to dental health through his innovative antibacterial compositions highlight the importance of research in improving oral care. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…